Meghnad Desai

The idea of Pakistan


Meghnad Desai

Sebi penalty on Ajmera Asso set aside

Ads by Google

The Securities Appellate Tribunal (SAT) today set aside penalty of Rs 1 lakh imposed by Sebi on Ajmera Associates for allegedly violating stock broker norms in case of Advik Laboratories shares.

Setting aside the penalty, SAT observed that Sebi's own findings in the matter had revealed that Ajmera Associates was not guilty of creating false market or that it had indulged in any act detrimental to the investor's interest.

Further the findings has also not proven that Ajmera Associates had not maintained high standards of integrity and fairness as required under norms for code of conduct for stock brokers.

" ...we fail to understand what other skill, care and diligence was required to be exercised by the appellant (Ajmera Associates) in the conduct of its business as a stock broker," SAT said in its order today.

"Even if the client's trading in the scrip (of Advik Laboratories) were with the connected persons, that by itself, is not enough to say that the due diligence of required standard was not maintained," it added.

Sebi had alleged the entity of trading, along with other brokers, in the scrip of Advik Laboratories on behalf of its clients, synchronising their trades, creating artificial volumes and price rise enabling the promoter shareholders to offload their shares at a higher price.

Stocks More on Advik Laboratories

Company INFO More on Advik Laboratories

Ads by Google
Please read our terms of use before posting comments
TERMS OF USE: The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).
comments powered by Disqus